ARTICLE | Company News
Axis-Shield, Hycor deal
August 1, 2011 7:00 AM UTC
Axis-Shield granted Hycor non-exclusive, worldwide rights to an anti-cyclic citrullinide biomarker for use in assays to diagnose rheumatoid arthritis (RA). Axis-Shield will be eligible for royalties. ...